Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2025-12-24 @ 3:57 PM
NCT ID:
NCT01522092
Eligibility Criteria:
Inclusion Criteria:
* Male/females aged between 40-80 years.
* Previous diagnosis of COPD confirmed by the GOLD criteria.
* At least two previous admissions to hospital for acute exacerbation of COPD.
* Physician diagnosed anxiety
* At least Mild anxiety score on HADS and GAD-7
* On a stable therapeutic regimen for COPD for 8 weeks prior to inclusion
* Known history of cigarette smoking at least 10 pack yrs
* Willing and able to comply with study procedures
* Able to provide written informed consent to participate
Exclusion Criteria:
* Current or past diagnosis of asthma
* Long-term oxygen therapy
* Currently on treatment with anti-depressives
* Serious inter-current illness (eg lung cancer)
* One year survival considered unlikely
* Patients who have evidence of alcohol or drug abuse
* Participation in another clinical trial with an investigational drug in four weeks preceding the screening visit
* Clinically significant or unstable concurrent disease e.g. left ventricular failure, diabetes mellitus
* Known or suspected hypersensitivity to escitalopram
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT01522092
Study Brief:
Protocol Section:
NCT01522092